Autoscribe has invited biobank experts to discuss compliance regulations at three UK seminars.
Dr Rod Westrop, CEO, Genesis Life Science Business Consultancy and Dr Mike Watts, Director Wolfson Cellular Therapy Unit, UCLH will join experts from Autoscribe and guest speakers to present seminars highlighting real-world biobank data management experiences.
The free, full-day events will be held in London on 7th March, Manchester on 12th March and Edinburgh on 23rd April and will share views and experiences on meeting compliance regulations while retaining the flexibility to meet individual application requirements.
They are particularly aimed at anyone involved in biobanks in biotechnology, pharmaceutical and medical research.
With the increasing number of biobank applications, the ability to manage an ever increasing number of bio-samples (blood, tissue, DNA etc.) and to comply with the regulatory requirements, such as HTA, GCLP, MHRA, FDA 21 CFR Part 11 and other similar requirements, is a high priority for many organisations.
Biobank management systems are frequently built from Laboratory Information Management Systems (LIMS) but need to be configured to deliver a solution that meets the specific requirements in a clearly understandable way.
